Valuation (21%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -8.48 | 43.50 |
PEG Ratio (TTM) | -0.24 | 3.98 |
P/S Ratio (TTM) | 0.35 | 4.17 |
P/B Ratio (TTM) | 1.40 | 7.37 |
P/FCF Ratio (TTM) | -29.69 | 67.79 |
Price to 5YR AVG Earnings Ratio | -19.88 | 47.20 |
Price to 5YR AVG FCF Ratio | -10.39 | 88.20 |
Profitability (5%) |
Company | Industry |
---|---|---|
ROA (TTM) | -3.02% | 5.01% |
ROE (TTM) | -15.42% | 19.15% |
Net Profit Margin (TTM) | -4.16% | 2.45% |
ROIC 5YR AVG | 4.28% | 9.56% |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -89.52% | -16.74% | -116.23% |
Revenue | 3.11% | 3.48% | 4.43% |
Net Income | -94.58% | -17.16% | -117.06% |
Cash Flow | 138.21% | 11,017.08% | 6,627.15% |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.26 | 0.95 |
Quick Ratio (TTM) | 0.67 | 0.90 |
D/E Ratio (TTM) | 2.89 | 1.58 |
Interest Coverage (TTM) | -1.07 | 6.49 |
Piotroski F-Score | 4 | 7 |
Altman Z-Score | 1.49 | 2.93 |
LTL to 5YR AVG FCF | -20.99 | 28.19 |
Shares Outstanding Growth 5YR AVG | -0.91% | 0.01% |